House lawmakers are introducing a bill that would give drug regulators more authority over compounding facilities.
The Compounding Clarity Act, introduced on Thursday by Reps. Gene Green (D-Texas), Morgan Griffith (R-Va.) and Diana DeGette (D-Colo.), would give the Food and Drug Administration (FDA) power to oversee major drug manufacturing facilities.
Read more: http://thehill.com/blogs/regwatch/legislation/322035-house-bill-gives-fda-new-power-over-compound-pharmacies#ixzz2ejReT24l
Follow us: @thehill on Twitter | TheHill on Facebook